Features of menopausal syndrome treatment in women with endometriosis

Authors

  • Н. Ф. Захаренко Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
  • Н. В. Коваленко Kyiv City Hospital number 9, Ukraine
  • Т. Ф. Татарчук SI “Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Ukraine https://orcid.org/0000-0002-5498-4143

DOI:

https://doi.org/10.18370/2309-4117.2016.29.60-66

Keywords:

menopause, endometriosis, anti-stress therapy, noofen, adaptol

Abstract

Correction of menopausal disorders on the endometriosis background has certain specificity, due to the fact that the menopausal hormone therapy in this group of women is extremely limited because of the possible endometriosis manifestations, which requires the development of new integrated scheme of nonhormonal therapy. Given the major impact of chronic stress in the mechanism of the endometriosis development and menopausal syndrome, authors found it necessary to use the anti-stress therapy for the treatment of this pathology. Authors had developed a treatment regimen without menopausal hormone therapy for women with mild to moderate climacteric syndrome and with history of endometriosis. Noofen was selected like the main drug as a stabilizer cognitive disorders and antihypoxant, as additional drug was used anxiolytic adaptol.

60 women with climacteric syndrome of mild to moderate severity and with history of endometriosis received treatment during the 6 weeks, which were divided into two groups of 30 women: the first group received monotherapy with noofen, women in the second group received the combined therapy that included adaptol and noofen.

Evaluation of the clinical status of patients and severity of menopausal disorders was conducted on a Menopause Rating Scale (MRS). The level of anxiety was measured on a Spielberg scale. Changing the assessment of life quality during therapy was determined by questionnaire Freiburg Personality Inventory (FPI).

The therapy result showed a significant improvement in the evaluated parameters in patients of both groups. In second group of women already in the first two weeks after complex therapy the improvements were found in comparison with the group receiving monotherapy. Thus, the chosen regimen helps to quickly eliminate the climacteric syndrome in women with endometriosis, improve and stabilize their psychological profile, recover, improve and adapt the quality of life.

Author Biographies

Н. Ф. Захаренко, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

MD, chief researcher at the Endocrine Gynecology Department

Н. В. Коваленко, Kyiv City Hospital number 9

Obstetrician-gynecologist of the Gynecological Department

Т. Ф. Татарчук, SI “Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”

MD, professor, corresponding member of NAMS of Ukraine, deputy director for research work, Chief of the Endocrine Gynecology Department

References

  1. Anisimov, V.N. Molecular and physiological mechanisms of aging. Sankt- Petersburg. Science (2003): 467 p.
  2. Burlaka, O.V., Stebliuk, V.V. “Evaluation of quality of life as a criterion for the efficiency of treatment and rehabilitation measures for reproductive function disorders.” Journal of physiotherapy and health resort 18.1 (2012): 75–9.
  3. Burchynskyi, S.G. “Brain aging and age pathology: from pharmacology to pharmacotherapy.” Messenger of Pharmacology 1 (2002): 12–7.
  4. Burchynskyi, S.G. “Nootropics as pharmacopreventive means: new strategies, new opportunities.” Practitioners Journal 1 (2003): 63–6.
  5. Vovk, I.B., Kondratiuk, V.K., Chubei, G.V., Zakharenko, N.F. “Treatment of genital endometriosis – from evolution to revolution (literature review).” Women’s Health 4 (2009): 40–3.
  6. Vovk, I.B., Homynska, Z.B., Zakharenko, N.F., Trokhymovych, O.F., Kovbasiy, V.P. “Characteristics of hormonal status in women with endometriosis.” Women’s Health 10.56 (2010): 162–4.
  7. Gilyatzudinov, I.A., Gilyatzudinova, Z.Sh. Neuroendocrine pathology in gynecology and obstetrics: a guideline for physicians. Moscow. MEDpress-inform (2006): 416 p.
  8. Zakharenko, N.F., Kosei, N.V., Kolomiets, L.M. “Endometriosis: a search for pharm therapy compromise.” Reproductive Endocrinology 2.4 (2012): 52–6.
  9. Zakharenko, N.F., Tatarchuk, T.F., Kovalenko, N.V. “The role of oxidative stress in the genesis of endometriosis.” Reproductive Endocrinology 4.18 (2014): 13–6.
  10. Zakharenko, N.F., Kovbasiy, V.P., Kovalenko, N.V. “Characteristics of psychological personality types in benign hyperproliferative diseases of the female reproductive system.” Women’s Health 2.48 (2010): 133–6.
  11. Zakharenko, N.F. “Clinical and anamnestic characteristics of women with different forms of endometriosis.” Pediatrics, Obstetrics and Gynecology: Scientific and Practical Journal 72.5 (2010): 97–104.
  12. Kovalenko, O.E., Zakharenko, N.F. “Psychophysical features of women with various endometriosis forms.” Phytotherapy: Scientific Journal 1 (2011): 46–9.
  13. Tatarchuk, T.F., Zakharenko, N.F., Manoliak, I.P., Kovbasiy, V.P. “Improving medical tactics in women with endometriosis.” Reproductive Endocrinology 4.18 (2014): 24–7.
  14. Tatarchuk, T.F., Zakharenko, N.F., Manoliak, I.P., Kovalenko, N.V., Kovbasiy, V.P. “Features of climacteric syndrome in women with endometriosis and possible ways of its correction.” Scientific journal of the Ministry of Health of Ukraine 2 (2014): 71–8.
  15. Tatarchuk, T.F. “Stress and women’s reproductive function.” International Journal of Endocrinology 3.5 (2006): 2–9.
  16. Tatarchuk, T.F., Yefymenko, O.A., Tutchenko, T.N. “Stress and involution of women’s reproductive system.” Reproductive Health of women 5.34 (2007): 153–6.
  17. Ancelin, M.L., Ritchie, K. “Lifelong endocrine fluctuations and related cognitive disorders.” Curr Pharm Des 11 (2005): 4229–52.
  18. Sherwin, B.B. “Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?” Ann NY Acad Sci 1052 (2005): 3–10.
  19. Soares, C.N. “Menopausal transition and depression: who is at risk and how to treat it?” Expert Rev Neurother 10 (2007): 1285–93.
  20. Räikkönen, K., Matthews, K.A., Kuller, L.H. “Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions.” Diabetes Care 4 (2007): 872–7.

Downloads

Published

2016-07-15

How to Cite

Захаренко, Н. Ф., Коваленко, Н. В., & Татарчук, Т. Ф. (2016). Features of menopausal syndrome treatment in women with endometriosis. REPRODUCTIVE ENDOCRINOLOGY, (29), 60–66. https://doi.org/10.18370/2309-4117.2016.29.60-66

Issue

No. 29 (2016)

Section

Management of menopause

License

Copyright (c) 2016 Н. Ф. Захаренко, Н. В. Коваленко, Т. Ф. Татарчук

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.